STAND. COM. REP. NO. 567-06

Honolulu, Hawaii

, 2006

RE: H.B. No. 3105

H.D. 2

 

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Third State Legislature

Regular Session of 2006

State of Hawaii

Sir:

Your Committees on Consumer Protection & Commerce and Judiciary, to which was referred H.B. No. 3105, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO PSYCHOTROPIC MEDICATION,"

beg leave to report as follows:

The purpose of this bill is to provide enhanced service to mental health consumers by, among other things, prohibiting the Department of Human Services (DHS) from restricting a physician's ability to treat fee-for-service mental health consumers with psychotropic medications that have been approved and designated as safe and effective by the FDA and are considered appropriate, within the scope of the physician's practice, for the treatment of mental health consumers.

The Hawaii Psychiatric Medical Association and Hawaii Disability Rights Center supported this bill. DHS supported the intent of this bill.

Although your Committees believe that this measure will improve access to necessary medications, further discussion on this matter is warranted.

Accordingly, your Committees have amended this bill by:

(1) Changing its effective date to July 1, 2096, to promote further discussion; and

(2) Making technical, nonsubstantive amendments for style, clarity, and consistency.

As affirmed by the records of votes of the members of your Committees on Consumer Protection & Commerce and Judiciary that are attached to this report, your Committees are in accord with the intent and purpose of H.B. No. 3105, H.D. 1, as amended herein, and recommend that it be referred to the Committee on Finance in the form attached hereto as H.B. No. 3105, H.D. 2.

Respectfully submitted on behalf of the members of the Committees on Consumer Protection & Commerce and Judiciary,

 

____________________________

SYLVIA LUKE, Chair

____________________________

ROBERT N. HERKES, Chair